A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant <i>K-ras</i>

Yanan Yang(The University of Texas MD Anderson Cancer Center), Jonathan M. Kurie(The University of Texas MD Anderson Cancer Center)
Molecular Cancer Therapeutics
April 1, 2008
Cited by 57


Related Papers